Kies je regio

Selecteer de regio die het beste past bij je locatie of voorkeuren.

International

Kies je sitetaal

Deze instelling regelt de taal van de gebruikersinterface, inclusief knoppen, menu's en alle tekst op de site. Selecteer je voorkeurstaal voor de beste browse-ervaring.

Kies de talen voor vacatures

Selecteer de talen voor vacatures die je wilt zien. Deze instelling bepaalt welke vacatures aan jou worden getoond.

Marie Skłodowska-Curie ITN-European Joint Doctorate - MOGLYNET

Milaan, Italië

Maak een e-mailalert aan

Website bezoeken

Over de werkgever

We are the MOGLYNET-PhD programme in drug discovery and development.

horizon-ibidi The Horizon 2020 MSCA joint doctoral project MoGglyNet (“Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study”) is run by a Consortium of Universities in cooperation with Industries and Associations operating in the Pharma sector with the aim to offer an innovative PhD level training in Drug Discovery and Development to 12 Early Stage Researchers.

The MOGLYNET PhD programme aims to define a new joint PhD educational model in Drug Discovery and Development and to promote institutional cooperation and mobility.

An active contribution of Industry in training activities is an important feature of the programme. The research methodologies and approaches proposed by the MOGLYNET consortium are strongly multidisciplinary and will involve a number of different state-of-the-art technologies and methodologies: Computational chemistry, Chemical synthesis; Bioanalytics and biophysics; In vitro biological evaluation; In vivo studies; Imaging; Metabolomics; Proteomics; Oxidative stress.